# Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects

> **NCT06015256** · NA · RECRUITING · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 448 (estimated)

## Conditions studied

- Asthma Acute

## Interventions

- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT06015256
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-07
- **Primary completion:** 2028-09
- **Final completion:** 2030-09
- **Target enrollment:** 448 (ESTIMATED)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015256, "Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06015256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*